Thursday, January 4, 2018

SomaLogic Snags $200M

Boulder-based Somalogic, a developer of technology used for analyzing proteins for personalized medicine and proteomics, has raised $200M in funding, the company said this morning. The funding came from iCarbonX, Nan Fung Life Sciencs, and Madryn Asset Management. SomaLogic says it "uniquely and precisely" measures thousands of human proteins rather than genes, which it uses to help improve individual health and wellness. SomaLogic is led by CEO Al Reynolds. More information »